184 related articles for article (PubMed ID: 35934822)
1. Efficacy of Antiresorptive Treatment in Osteoporotic Older Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Cedeno-Veloz BA; Erviti Lopez J; Gutiérrez-Valencia M; Leache Alegría L; Saiz LC; Rodríguez García AM; Sánchez Latorre M; Ramírez Vélez R; Izquierdo M; Martínez-Velilla N
J Nutr Health Aging; 2022; 26(8):778-785. PubMed ID: 35934822
[TBL] [Abstract][Full Text] [Related]
2. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
[TBL] [Abstract][Full Text] [Related]
3. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
Wells GA; Hsieh SC; Zheng C; Peterson J; Tugwell P; Liu W
Cochrane Database Syst Rev; 2022 May; 5(5):CD004523. PubMed ID: 35502787
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men.
Avenell A; Mak JC; O'Connell D
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD000227. PubMed ID: 24729336
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D.
Hara T; Hijikata Y; Matsubara Y; Watanabe N
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013424. PubMed ID: 34231877
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials.
Händel MN; Cardoso I; von Bülow C; Rohde JF; Ussing A; Nielsen SM; Christensen R; Body JJ; Brandi ML; Diez-Perez A; Hadji P; Javaid MK; Lems WF; Nogues X; Roux C; Minisola S; Kurth A; Thomas T; Prieto-Alhambra D; Ferrari SL; Langdahl B; Abrahamsen B
BMJ; 2023 May; 381():e068033. PubMed ID: 37130601
[TBL] [Abstract][Full Text] [Related]
8. Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.
Bell JM; Shields MD; Watters J; Hamilton A; Beringer T; Elliott M; Quinlivan R; Tirupathi S; Blackwood B
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010899. PubMed ID: 28117876
[TBL] [Abstract][Full Text] [Related]
9. Effect of medications on prevention of secondary osteoporotic vertebral compression fracture, non-vertebral fracture, and discontinuation due to adverse events: a meta-analysis of randomized controlled trials.
Jin YZ; Lee JH; Xu B; Cho M
BMC Musculoskelet Disord; 2019 Aug; 20(1):399. PubMed ID: 31472671
[TBL] [Abstract][Full Text] [Related]
10. Exercise for improving outcomes after osteoporotic vertebral fracture.
Gibbs JC; MacIntyre NJ; Ponzano M; Templeton JA; Thabane L; Papaioannou A; Giangregorio LM
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD008618. PubMed ID: 31273764
[TBL] [Abstract][Full Text] [Related]
11. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
[TBL] [Abstract][Full Text] [Related]
12. Cephalomedullary nails versus extramedullary implants for extracapsular hip fractures in older adults.
Lewis SR; Macey R; Gill JR; Parker MJ; Griffin XL
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD000093. PubMed ID: 35080771
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates for steroid-induced osteoporosis.
Allen CS; Yeung JH; Vandermeer B; Homik J
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD001347. PubMed ID: 27706804
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture.
Buchbinder R; Johnston RV; Rischin KJ; Homik J; Jones CA; Golmohammadi K; Kallmes DF
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD006349. PubMed ID: 29618171
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis.
Saito T; Sterbenz JM; Malay S; Zhong L; MacEachern MP; Chung KC
Osteoporos Int; 2017 Dec; 28(12):3289-3300. PubMed ID: 28770272
[TBL] [Abstract][Full Text] [Related]
16. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture.
Buchbinder R; Johnston RV; Rischin KJ; Homik J; Jones CA; Golmohammadi K; Kallmes DF
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD006349. PubMed ID: 30399208
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture.
Buchbinder R; Golmohammadi K; Johnston RV; Owen RJ; Homik J; Jones A; Dhillon SS; Kallmes DF; Lambert RG
Cochrane Database Syst Rev; 2015 Apr; (4):CD006349. PubMed ID: 25923524
[TBL] [Abstract][Full Text] [Related]
19. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
Wells G; Cranney A; Peterson J; Boucher M; Shea B; Robinson V; Coyle D; Tugwell P
Cochrane Database Syst Rev; 2008 Jan; (1):CD004523. PubMed ID: 18254053
[TBL] [Abstract][Full Text] [Related]
20. Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis.
Merlijn T; Swart KMA; van der Horst HE; Netelenbos JC; Elders PJM
Osteoporos Int; 2020 Feb; 31(2):251-257. PubMed ID: 31838551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]